USPTO serial 79120454
UCX
Reviewed by CopyMark Law Group
Reg. 4427095Status 404
- Filing date
- Status date
- Registration date
- Nov 5, 2013
- Examiner
- HALMEN, KATHERINE E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with UCX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
ECBIO, INVESTIGAÇÃO E DESENVOLVIMENTO EM BIOTECNOLOGIA, S.A.
P-2700-451 AMADORA, PT
Other trademarks owned by ECBIO, INVESTIGAÇÃO E DESENVOLVIMENTO EM BIOTECNOLOGIA, S.A.
ECBIO, INVESTIGAÇÃO E; DESENVOLVIMENTO EM; BIOTECNOLGIA, S.A.
P-2700-451 AMADORA, PT
Other trademarks owned by ECBIO, INVESTIGAÇÃO E; DESENVOLVIMENTO EM; BIOTECNOLGIA, S.A.
ECBIO, INVESTIGAÇÃO E; DESENVOLVIMENTO EM; BIOTECNOLGIA, S.A.
P-2700-451 AMADORA, PT
Other trademarks owned by ECBIO, INVESTIGAÇÃO E; DESENVOLVIMENTO EM; BIOTECNOLGIA, S.A.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John Alumit
John Alumit ALUMIT IP135 South Jackson Street, Suite 200Glendale, CA 91205UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of cardiovascular diseases, ischemic myocardium, peripheral artery disease, wounds, autoimmune diseases, rheumatoid arthritis, Crohn's disease and diseases related thereto, degenerative diseases, and central or peripheral nerve regeneration; Biological preparations for the treatment of cardiovascular diseases, ischemic myocardium, peripheral artery disease, wounds, autoimmune diseases, rheumatoid arthritis, Crohn's disease and diseases related thereto, degenerative diseases, and central or peripheral nerve regeneration | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ECBIO, INVESTIGAÇÃO E DESENVOLVIMENTO EM BIOTECNOLOGIA, S.A.
- Other trademarks owned by ECBIO, INVESTIGAÇÃO E; DESENVOLVIMENTO EM; BIOTECNOLGIA, S.A.
- Other trademarks owned by ECBIO, INVESTIGAÇÃO E; DESENVOLVIMENTO EM; BIOTECNOLGIA, S.A.
- Other trademarks in Class 005
- Similar marks named UCX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 17, 2023 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Apr 17, 2023 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jan 9, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Nov 17, 2021 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Nov 17, 2021 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Oct 26, 2021 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 26, 2021 | C71T | CANCELLED SECTION 71 | — |
| Oct 11, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 15, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 5, 2018 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 2, 2014 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Mar 20, 2014 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Feb 28, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 7, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 7, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 5, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 5, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 20, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 20, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 31, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 16, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 15, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 12, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 12, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 5, 2013 | ALIE | ASSIGNED TO LIE | — |
| Jun 2, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 14, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 22, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 22, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 22, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 21, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 21, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 4, 2012 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 28, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 22, 2012 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |